Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
4.715
-0.075 (-1.57%)
Jun 29, 2026, 9:59 AM EDT - Market open
Aardvark Therapeutics Employees
Aardvark Therapeutics had 40 employees as of December 31, 2025. The number of employees increased by 18 or 81.82% compared to the previous year.
Employees
40
Change (1Y)
18
Growth (1Y)
81.82%
Revenue / Employee
n/a
Profits / Employee
-$1,746,725
Market Cap
102.86M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 40 | 18 | 81.82% |
| Dec 31, 2024 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cibus | 118 |
| Alps Group | 93 |
| Pelthos Therapeutics | 92 |
| Vivani Medical | 42 |
| Cue Biopharma | 29 |
| Oncolytics Biotech | 29 |
| Black Diamond Therapeutics | 21 |
| Cognition Therapeutics | 14 |
AARD News
- 4 days ago - Aardvark Therapeutics (AARD) Faces Investor Scrutiny Amid 56% Drop On Clinical Pause For Lead Drug Candidate- HBSS - PRNewsWire
- 6 weeks ago - Aardvark Therapeutics downgraded to Underperform from Buy at BofA - TheFly
- 6 weeks ago - Aardvark Therapeutics price target lowered to $7 from $8 at B. Riley - TheFly
- 6 weeks ago - Aardvark Therapeutics Inc trading halted, volatility trading pause - TheFly
- 6 weeks ago - Aardvark Therapeutics Inc trading resumes - TheFly
- 6 weeks ago - Aardvark Therapeutics downgraded to Neutral from Buy at BTIG - TheFly
- 6 weeks ago - Aardvark downgraded to Underweight from Equal Weight at Morgan Stanley - TheFly
- 6 weeks ago - Aardvark Therapeutics announces FDA clinical hold on ARD-101 - TheFly